Valuation Entheon Biomedical Corp.

Equities

Delayed Canadian Securities Exchange Other stock markets 12:49:04 2024-12-12 pm EST			5-day change	1st Jan Change
0.1700 ^CAD	0.00%		+6.25%	+70.00%

Dec. 02	Entheon Biomedical Corp. announced that it expects to receive CAD 0.3 million in funding	CI
Oct. 24	Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024	CI

Data adjusted to current consolidation scope

Fiscal Period: November	2020	2021	2022	2023
Capitalization ¹	30.7	31.88	1.773	0.5909
Change	-	3.86%	-94.44%	-66.67%
Enterprise Value (EV) ¹	27.86	29.83	1.093	0.2463
Change	-	7.08%	-96.34%	-77.46%
P/E ratio	-4.76x	-3.3x	-0.21x	-1.97x
PBR	8.2x	3.53x	2.88x	1.87x
PEG	0.1x	-1.31x	0x	0x
Capitalization / Revenue	-	1,471,213,659x	9,345,767x	2,360,518x
EV / Revenue	-	1,376,652,930x	5,759,850x	983,765x
EV / EBITDA	-17,007,259x	-3,288,893x	-308,369x	-
EV / EBIT	-17x	-3.28x	-0.3x	-0.78x
EV / FCF	-14,371,381x	-13,929,199x	-641,929x	-978,084x
FCF Yield	-0%	-0%	-0%	-0%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-1.597	-1.637	-1.442	-0.0508
Distribution rate	-	-	-	-
Net sales	-	0.0217	0.1897	0.2503
EBITDA	-1.638	-9.071	-3.543	-
EBIT ¹	-1.641	-9.106	-3.6	-0.314
Net income ¹	-4.381	-8.887	-8.521	-0.3
Net Debt ¹	-2.837	-2.049	-0.6802	-0.3446
Reference price ²	7.6000	5.4000	0.3000	0.1000
Nbr of stocks (in thousands)	4,039	5,904	5,909	5,909
Announcement Date	3/30/21	3/30/22	3/23/23	3/26/24

¹CAD in Million²CAD

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
LONZA GROUP AG	44.35x	6.17x	21.9x	+0.86%	42.67B
IQVIA HOLDINGS INC.	27.39x	3.18x	13.25x	-.--%	36.49B
CELLTRION, INC.	87.18x	11.21x	40.18x	+0.27%	26.56B
ICON PUBLIC LIMITED COMPANY	24.39x	2.43x	11.63x	-.--%	17.52B
MODERNA, INC.	-4.58x	2.54x	-2.33x	-.--%	16.49B
UNITED THERAPEUTICS CORPORATION	14.78x	4.86x	9.42x	-.--%	16.17B
BIO-TECHNE CORPORATION	63.93x	9.9x	28.19x	+0.42%	12.2B
MEDPACE HOLDINGS, INC.	28.55x	4.78x	21.92x	-.--%	10.59B
QIAGEN N.V.	62.4x	5.31x	14.32x	-.--%	10.26B
Average	38.71x	5.60x	17.61x	+0.17%	20.99B
Weighted average by Cap.	39.80x	5.64x	18.66x	+0.26%